RESUMO
Penile and preputial tumours are not uncommon in the horse, but can cause discomfort and lead to serious complications. Several types of tumour of the male external genitalia have been described. The most common type is the squamous cell carcinoma (SCC), which is found mainly in older horses. Reports of a breed predilection for penile tumour formation are equivocal, but castration, coat colour, poor hygiene and various infectious agents have all been suggested to predispose to the development of some types of tumour (e.g. SCC, papilloma and melanoma). Careful assessment of the primary tumour is an important first step in the design of an optimal treatment protocol. Invasiveness, differentiation grade, tumour size and presence of metastases are all relevant to the decision to pursue additional diagnostic procedures or specific treatment options. To date, no standard protocol has been reported for the approach to penile tumours in the horse and treatments range from minimally invasive therapies (e.g. topical use of 5-fluorouracil) to radical surgical interventions (e.g. en bloc penile and preputial resection with penile retroversion). Completeness of removal of the neoplasm and therefore risk of recurrence is highly dependent on the type of therapy chosen. However, the size and histopathological features of the primary tumour are also important factors with respect to the likelihood of recurrence. This review describes the most common penile and preputial neoplasms in the horse, and outlines a standard protocol aimed at arriving at a specific diagnosis and tailoring the therapeutic approach accordingly.
Assuntos
Neoplasias dos Genitais Masculinos/veterinária , Doenças dos Cavalos/terapia , Animais , Neoplasias dos Genitais Masculinos/terapia , Cavalos , MasculinoRESUMO
REASONS FOR PERFORMING STUDY: Infundibular changes are frequently encountered computed tomographic studies of the equine maxillary cheek teeth but the possible importance of this finding is not known. Infundibular caries is a possible cause for pulpitis and apical infection in some horses. OBJECTIVES: To study the relationship between the 2 pathologies and the frequency of changes. METHODS: The maxillary cheek teeth 108-208, 109-209 and 110-210 of 25 horses were evaluated using computed tomography and both the prevalence of infundibular and apical infection changes as the possible link with apical infection evaluated statistically. RESULTS: The prevalence of infundibular changes was high in both normal and diseased teeth. Both apical infection and the occurrence of infundibular changes were more prevalent in 109-209 and 110-210. In spite of this, the 2 processes could not be linked to one another. No differences were noted between the left and right sides. CONCLUSIONS: A direct relationship between the 2 processes was not established statistically and other underlying causes for the high occurrence of both apical infection and infundibular changes in diseased and normal 108-208, 109-209 and 110-210 are considered.
Assuntos
Doenças dos Cavalos/diagnóstico por imagem , Dente Molar/diagnóstico por imagem , Abscesso Periapical/veterinária , Tomografia Computadorizada por Raios X/veterinária , Animais , Cárie Dentária/veterinária , Cavalos , Abscesso Periapical/diagnóstico por imagemRESUMO
REASONS FOR PERFORMING STUDY: Preputial and penile tumours are more common in horses than in other domestic animals, but no large surveys of male horses with tumours of the external genitalia are available. OBJECTIVE: To present a retrospective analysis of male horses with neoplasms of the external genitalia. METHODS: The penile and preputial tumours of 114 horses were evaluated. Data recorded included age, gelding or stallion and breed; type and site of lesion; involvement of regional lymph nodes; histopathology (including grading of squamous cell carcinoma); and results of radiographic examination of the thorax. RESULTS: Mean age of horses was 19.5 years with no apparent breed predilection. Common presenting clinical signs were irregularities (e.g. the presence of a mass and/or ulceration) on the integument of the penis and prepuce, and purulent or sanguineous discharge from preputial orifice. Squamous cell carcinoma (SCC) was the most prevalent neoplasm followed by papillomas and melanomas. A basal cell carcinoma, neurofibrosarcoma, adenocarcinoma or fibrosarcoma were each found on single horses. Squamous cell carcinomas with poor differentiation had a higher tendency to metastasise than did more differentiated tumours. CONCLUSIONS: Squamous cell carcinoma is the most common urogenital tumour of the male horse and occurs primarily in old horses. Horses with poorly differentiated SCCs tend to have a higher incidence of regional metastases. Pathology of lymph nodes, even when not palpably enlarged, is a valuable diagnostic exercise. Radiology of the thorax to detect lung metastases is of little value.
Assuntos
Carcinoma de Células Escamosas/veterinária , Doenças dos Cavalos/patologia , Neoplasias Penianas/veterinária , Fatores Etários , Animais , Cruzamento , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Doenças dos Cavalos/epidemiologia , Doenças dos Cavalos/cirurgia , Cavalos , Linfonodos/patologia , Linfonodos/cirurgia , Metástase Linfática/diagnóstico , Masculino , Metástase Neoplásica/diagnóstico , Estadiamento de Neoplasias/veterinária , Orquiectomia/veterinária , Papiloma/epidemiologia , Papiloma/patologia , Papiloma/cirurgia , Papiloma/veterinária , Linhagem , Neoplasias Penianas/epidemiologia , Neoplasias Penianas/patologia , Neoplasias Penianas/cirurgia , Pênis/patologia , Pênis/cirurgia , Estudos Retrospectivos , Uretra/patologia , Uretra/cirurgiaRESUMO
REASONS FOR PERFORMING STUDY: The most common penile and preputial neoplasm in the horse is the squamous cell carcinoma (SCC), but no large surveys of treatment and effects of the grade of the tumour, based on the degree of differentiation, on outcome of affected horses are available. OBJECTIVES: Analysis of treatment of male horses affected with SCC of the external genitalia and long-term results of treatment. METHODS: Seventy-seven cases of SCC were evaluated. Data recorded included treatment, outcome, post operative histopathology and retrospective tumour grading. RESULTS: Treatments included: cryosurgery, excision, partial phallectomy, partial phallectomy and sheath ablation, and en bloc penile and preputial resection with penile retroversion and removal of inguinal lymph nodes. The incidence of recurrence after partial phallectomy was 25.6% (10/39) and following incomplete removal was 17.9% (7/39). The incidence of recurrence after en bloc resection with retroversion was 12.5% (1/8). In horses with confirmed inguinal lymph node metastasis, the incidence of recurrence was 25.0% (1/4). Poorly differentiated SCCs were more likely to metastasise than well differentiated SCCs, and there was a greater chance that the treatment would be unsuccessful. The success of treatment, complete removal and in preventing recurrence of the tumour, of male horses with SCC of the external genitalia was 55.7%. CONCLUSIONS: Horses that receive only partial phallectomy for treatment for SCC of the external genitalia have a high incidence of recurrence in contrast to horses that receive an en bloc resection. Tumour grading of SCC can help predict prognosis and guide selection of treatment.
Assuntos
Carcinoma de Células Escamosas/veterinária , Doenças dos Cavalos/cirurgia , Neoplasias Penianas/veterinária , Amputação Cirúrgica/veterinária , Animais , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/cirurgia , Doenças dos Cavalos/mortalidade , Doenças dos Cavalos/patologia , Cavalos , Canal Inguinal/cirurgia , Excisão de Linfonodo/veterinária , Linfonodos/patologia , Metástase Linfática , Masculino , Metástase Neoplásica , Recidiva Local de Neoplasia/epidemiologia , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/veterinária , Estadiamento de Neoplasias/veterinária , Neoplasias Penianas/mortalidade , Neoplasias Penianas/patologia , Neoplasias Penianas/cirurgia , Pênis/cirurgia , Prognóstico , Estudos Retrospectivos , Resultado do TratamentoRESUMO
Cows of the Dutch Frisian and Maas-Rijn-IJssel breed with histologically confirmed ocular squamous cell carcinoma showed complete regression of the primary tumor in 70 or 60% of the cases after intralesional injection of a BCG cell wall or live BCG vaccine, respectively. Recurrence of the tumor was observed in 57% of the animals treated with BCG cell walls and in 25% of the animals treated with live BCG vaccine. Spontaneous regression was seen in 20% of the untreated cows. In a second control group, radical surgery, the most successful treatment for primary stage I tumors in humans, resulted in a 90% cure. Influence of immunotherapy on metastases could not yet be fully evaluated. White blood cell counts were not changed after therapy. It was not possible to link a favorable response to BCG therapy with the intensity of the delayed type hypersensitivity (DTH) reaction to purified protein derivative of mycobacteriae (PPD) or the formation of antibodies to BCG as determined by a micro-enzyme-linked immunosorbent assay. However, in animals that showed tumor regression, the DTH reaction to PPD had a tendency to persist for a longer period of time. It was concluded that 1) block resection was the best method of treatment for this tumor, 2) a single intralesional injection of a BCG cell wall vaccine was as effective as live BCG vaccine in the induction of complete regression of the primary tumor, 3) in this preliminary study BCG cell wall vaccine was less effective than live BCG vaccine in the prevention of recurrence, and 4) this naturally occurring tumor model is well suited for the study of the influence of BCG immunotherapy in a primary stage I tumor.
Assuntos
Vacina BCG/administração & dosagem , Carcinoma de Células Escamosas/veterinária , Doenças dos Bovinos/terapia , Neoplasias Oculares/veterinária , Animais , Vacina BCG/uso terapêutico , Carcinoma de Células Escamosas/imunologia , Carcinoma de Células Escamosas/terapia , Bovinos , Doenças dos Bovinos/imunologia , Modelos Animais de Doenças , Neoplasias Oculares/imunologia , Neoplasias Oculares/terapia , Feminino , Hipersensibilidade Tardia/imunologia , Contagem de LeucócitosRESUMO
The aminoglycoside gentamicin is often used in equine practice. Despite its clinical use, concerns remain regarding the potential toxic side-effects, such as nephrotoxicity, in equine patients, particularly after repeated dosing. The aim of the study was to investigate first in vitro the mechanisms contributing to the renal toxicity of gentamicin and to identify sensitive biomarkers indicating proximal tubule damage. To this end, the kidney-derived cell lines LLC-PKI and MDCK were treated with gentamicin at different concentrations. Toxicity was assessed by measuring the release of gamma-glutamyl transferase (GGT), and the production of reactive oxygen species (ROS). Cell viability was measured using Alamar blue (AB) and Neutral red (NR) cytotoxicity assays. Gentamicin exerted a dose-dependent toxicity. Primarily, loss of brush border membrane integrity, indicated by GGT leakage, and an increased ROS production were observed. As GGT was found to be a sensitive marker for gentamicin-induced renal cell injury, in the subsequent in vivo experiments, in which ponies were given gentamicin (3.0 mg/kg bw three times daily and 4.5 mg/kg bw twice daily) for five consecutive days, plasma levels and the urinary excretion of GGT and creatinine were measured and the GGT:creatinine ratio was calculated. Elevated GGT levels in urine following gentamicin therapy were observed, but this enzyme leakage was transient and returned to baseline values after cessation of therapy. It could thus be concluded that even a conservative dose regimen of gentamicin did not result in significant renal toxicity in healthy ponies.
Assuntos
Antibacterianos/toxicidade , Gentamicinas/toxicidade , Túbulos Renais Distais/efeitos dos fármacos , Túbulos Renais Proximais/efeitos dos fármacos , Animais , Antibacterianos/farmacocinética , Biomarcadores/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Creatinina/metabolismo , Cães , Relação Dose-Resposta a Droga , Imunoensaio de Fluorescência por Polarização/veterinária , Gentamicinas/farmacocinética , Cavalos , Túbulos Renais Distais/enzimologia , Túbulos Renais Distais/patologia , Túbulos Renais Proximais/enzimologia , Túbulos Renais Proximais/patologia , Células LLC-PK1 , Masculino , Vermelho Neutro , Oxazinas , Espécies Reativas de Oxigênio/metabolismo , Suínos , Xantenos , gama-Glutamiltransferase/metabolismoRESUMO
The aminoglycoside antibiotic gentamicin is commonly used in equine medicine for the prevention and treatment of Gram-negative and staphylococcal bacteria in surgically treated colic patients. The pharmacokinetics of gentamicin in these patients might be altered by the disease status, and/or under the influence of fluid therapy. The purpose of this study was to investigate the effect of intravenous fluid treatment on gentamicin kinetics in colic patients. Colic patients subjected to laparotomy were given fluid infusions according to clinical status. Following gentamicin administration, blood samples were taken for gentamicin analysis at different time points, and the main pharmacokinetic parameters including Vc, Vss, t(1/2) and MRT were calculated. Horses undergoing fluid therapy showed a significantly different t(1/2), clearance and MRT as compared to non-infused patients. However, taking into account the clinical status of the patients receiving fluid support, the data suggest that endotoxaemia, rather than fluid therapy, influence gentamicin pharmacokinetics following laparotomy.
Assuntos
Antibacterianos/farmacocinética , Cólica/veterinária , Hidratação/veterinária , Gentamicinas/farmacocinética , Doenças dos Cavalos/terapia , Animais , Cólica/tratamento farmacológico , Terapia Combinada/veterinária , Doenças dos Cavalos/metabolismo , Cavalos , Fatores de TempoRESUMO
Four cows bearing large Ocular Squamous Cell Carcinomas (BOSCC) were treated by 10 intratumoral injections (Monday-Friday for 2 consecutive weeks) of 200,000 U Interleukin-2 (Cetus). Tumors regressed in 2 out of 4 cases. This result shows that even large tumors may regress after local IL-2 treatment.
Assuntos
Carcinoma de Células Escamosas/veterinária , Doenças dos Bovinos/terapia , Neoplasias Palpebrais/veterinária , Interleucina-2/administração & dosagem , Animais , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/terapia , Bovinos , Doenças dos Bovinos/patologia , Neoplasias Palpebrais/patologia , Neoplasias Palpebrais/terapia , Feminino , Injeções IntralesionaisRESUMO
Bovine ocular squamous cell carcinoma (BOSCC) is sensitive to intralesional immunotherapy with BCG or recombinant human IL-2 (rhIL-2). The mechanism of tumor regression is as yet unclear. Alterations in the concentration of IL-2 (and possibly other factors) in the tumor, due to regional injection or induction by BCG, may induce killer cell activity and thus tumor regression. To investigate this, lymphocytes were isolated by mechanical fractionation of biopsies of BOSCC. Growth, phenotypical, and functional characteristics were studied. TIL could be isolated and grown from all biopsies of BOSCC. An estimated increase in cell number of 50-150 fold was observed during 5-7 weeks of culture. FACS analysis of a limited number of the TIL cultures showed a characteristic shift in phenotypes until day 28 of culture. CD2+ cells (50-70%), and as a consequence of this CD2- cells, remained stable in number. The number of CD8+ cells increased. CD4+ cells were detected in low numbers by day 28. Prolonged culture resulted in an increase of CD2- gamma delta + cells, CD2+4-8- cells, and occasionally of both CD8+ and CD2+ cells. In 51Cr release assays TIL showed cytotoxicity for BOSCC-derived tumor cell lines in general, which increased transiently by cocultivation with tumor cells. Killing of YAC-1, and P815 was far less efficient. Preferential killing of autologous cell lines was not seen. In conclusion, TIL from bovine ocular squamous cell carcinomas can be cultured in the presence of rhIL-2, which induces cytotoxic activity for BOSCC-derived tumor cells. Cells responsible for killing in vitro and potentially for regression of the tumor after immunotherapy with BCG or rhIL2 cannot yet be identified. Depletion and blocking experiments are being conducted in order to identify the cells (CD2+8+, CD2-gamma delta + or other CD2 +/-) responsible for killing.
Assuntos
Carcinoma de Células Escamosas/veterinária , Doenças dos Bovinos/terapia , Neoplasias Oculares/veterinária , Linfócitos do Interstício Tumoral/imunologia , Animais , Antígenos CD/análise , Carcinoma de Células Escamosas/imunologia , Carcinoma de Células Escamosas/terapia , Bovinos , Doenças dos Bovinos/imunologia , Divisão Celular , Separação Celular , Citotoxicidade Imunológica , Neoplasias Oculares/imunologia , Neoplasias Oculares/terapia , Feminino , Imunoterapia , FenótipoRESUMO
In hereditary cancers the responsible inherited cancer genes are defective (mutated) anti-oncogenes (tumour suppressor genes). This inherited mutation is present in all cells of the organism, and only leads to cancer if in a somatic cell a complete set of specific cancer mutations is accumulated. Since one defective anti-oncogene has been inherited, only three additional somatic cancer mutations are required, according to our previously published view (Anticancer Res 10:1990). The number of de novo arising tumour cells in such a person is thus multiplied by a factor equal to the reverse of the mutant frequency, that is about 10(4)-10(5). This can be observed e.g. in retinoblastoma. Mutations occur in proliferating cells only. Consequently cancer mutations also depend on cell proliferation. If an inherited cancer mutation predisposes to cancer formation in certain organs, then the cancer risk in these organs is enhanced by 10(4)-10(5) times. Tumours in these organs will appear simultaneously if the number of cells and the growth kinetics are similar. This is of course observed in paired organs, like the retina and the female breast. In cancer family syndromes different organs may be affected at the same time. Examples are type I and type II cancer family syndrome and multiple endocrine neoplasia type 1 2a, and 2b. The secondly diagnosed tumours are not caused by metastatic spread. Tumours in two organs will arise at difference times if the number of end cells per organ and the growth kinetics differ. In this case the second tumour is called a second primary malignancy and is not caused by metastatic spread. A good example are the second primary malignancies in hereditary retinoblastoma. The inherited defective anti-oncogene is a recessive gene. This defective inherited gene causes a 10(4)-10(5) fold increase of the normal tumour incidence. This means that nearly always one or more tumours will arise. Evidently, this pattern of inheritance has led to the erroneous conclusion that the genetic abnormality is dominant at the level of the chromosome. The 10(4)-10(5) times enhanced tumour incidence in hereditary cancer is helpful for the clinical recognition of hereditary cancer. That is, hereditary cancer can be recognized not only by family history, but also by early occurrence, the multifocal and bilateral localisation, its occurrence as cancer family syndrome or by second primary malignancies. It is thus recommended to screen patients and families with hereditary cancer for first and second primary tumours. Treatment of patients with hereditary tumours requires extra care to avoid additional cancer mutations.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Neoplasias/genética , Genes Dominantes , Humanos , Mutação , Neoplasias/terapia , Oncogenes , Supressão GenéticaRESUMO
In many human clinical trials and in various animal tumor models, the antitumor effect of high doses of systemically applied interleukin-2 (IL-2) is tested. Our studies focused on the effects of low doses of locally injected IL-2. In this paper, the effect of local injection of low doses of IL-2, i.e. a total dose of 25,000-50,000 units, into papillomas or carcinomas of the bovine vulva is described. In 19 out of 23 (83%) cows treated with IL-2 an effect on the tumor load was observed; in three of these animals, complete regression was obtained. In the majority of cases, regression was not restricted to the tumors injected with IL-2.
Assuntos
Carcinoma/veterinária , Doenças dos Bovinos/tratamento farmacológico , Interleucina-2/uso terapêutico , Papiloma/veterinária , Neoplasias Vulvares/veterinária , Animais , Carcinoma/tratamento farmacológico , Bovinos , Feminino , Seguimentos , Imunoterapia/veterinária , Injeções Intralesionais/veterinária , Interleucina-2/administração & dosagem , Papiloma/tratamento farmacológico , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/uso terapêutico , Indução de Remissão , Neoplasias Vulvares/tratamento farmacológicoRESUMO
Horses with sarcoids, cows with ocular squamous cell carcinoma and dogs with mammary tumors were treated with intralesional injection of Bacillus Calmette Guérin. This treatment appeared to be effective in most cases of equine sarcoids, in 50 - 60% of the cows with ocular squamous cell carcinoma and was not effective in dogs with mammary tumors.
Assuntos
Vacina BCG/uso terapêutico , Doenças do Cão/terapia , Doenças dos Cavalos/terapia , Neoplasias/veterinária , Doenças dos Suínos/terapia , Animais , Carcinoma de Células Escamosas/terapia , Bovinos , Cães , Neoplasias Oculares/terapia , Feminino , Cavalos , Neoplasias Mamárias Animais/terapia , Neoplasias/terapia , Sarcoidose/terapia , SuínosRESUMO
IL-2 treatment for metastatic tumors in man is usually given systemically with high doses, often in conjunction with large numbers of LAK-cells. Complete tumor regression is obtained in less than 10%, this treatment causes severe toxicity, and culturing of LAK-cells is laborious and expensive. In this paper we demonstrate that small amounts of locally applied rIL-2 alone, if given at the right time, can cure about 70% of DBA/2 mice with large metastasized syngeneic SL2 lymphoma comprising 4-10% of the total body weight, a tumor load hitherto considered fatal. Moreover, 3 out of 5 cows with ocular squamous cell carcinoma (BOSCC) of 1 x 1 up to 3 x 4 cm were cured with low doses of rIL-2 only. Taken together, we have now tested 11 tumors in animals. No antitumor effect was observed in EL4 lymphoma in C57BL mice. Partial antitumor effects were detected in RBL5 lymphoma in C57BL mice, stomach carcinoma in BALB/c mice, MOT-carcinoma in C3H mice, liver carcinoma in guinea pigs and bovine vulval papilloma/carcinoma. Complete tumor regression was obtained in SL2 lymphoma, L5178Y lymphoma, L1210 lymphoma, and P815 mastocytoma in DBA/2 mice and in bovine ocular squamous cell carcinoma. Low doses of locally injected IL-2 induce systemic immunity, as shown in DBA/2 mice bearing syngeneic SL2 lymphoma cells. We conclude that local low dose treatment can be effective and results in a high cure rate in several tumor models. In the DBA/2-SL2 lymphoma model this treatment is 100-1000 times more effective than any form of immunotherapy we have tested during 20 years in this model.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Imunoterapia/métodos , Interleucina-2/administração & dosagem , Células Matadoras Ativadas por Linfocina/imunologia , Neoplasias/terapia , Animais , Carcinoma de Células Escamosas/terapia , Bovinos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Linfoma/terapia , Camundongos , Camundongos Endogâmicos DBA , Proteínas Recombinantes/administração & dosagemRESUMO
Nine Friesian sheep (age 1.5-2 years) were used to evaluate the quality of bone repair in artificial cleft-like maxillary defects repaired with autologous bone grafts of embryologically different origin. After bilateral extraction of the upper first deciduous molar the tooth socket was enlarged resulting in an open connection between the oral and nasal cavities. In the same session a graft, obtained from the iliac crest, was implanted in one of the two bilateral maxillary defects and on the opposite side a graft, obtained from the mandible, was inserted. During the experiment, serial radiographs were taken. After six months the sheep were sacrificed and the bone of the grafted areas was submitted to histological and histomorphometric investigation. Comparing both areas, it appeared that the quality of bone remodelling and alveolar reconstruction was independent of the origin of the grafts.
Assuntos
Ílio/transplante , Mandíbula/transplante , Maxila/cirurgia , Processo Alveolar/diagnóstico por imagem , Processo Alveolar/patologia , Alveoloplastia , Animais , Densidade Óssea , Transplante Ósseo , Ílio/patologia , Mandíbula/patologia , Maxila/diagnóstico por imagem , Maxila/patologia , Osteoblastos/patologia , Osteoclastos/patologia , Osteogênese , Radiografia , Ovinos , Transplante Autólogo , CicatrizaçãoRESUMO
Interleukin-2 (IL-2) is a powerful drug for treating cancer. However, it is only powerful if it is properly applied. That is, IL-2 should be applied at the tumor site, because at the transition of normal and malignant tissue are the tumor infiltrating cells. These should be activated by IL-2. Local application implies that IL-2 can be used in relatively low doses. It is becoming clear that even a single injection of IL-2 can cure cancer. IL-2 can also enhance the therapeutic effects of irradiation and Cisplatin. Locally applied IL-2 therapy is virtually non-toxic.
Assuntos
Interleucina-2/administração & dosagem , Neoplasias/terapia , Animais , Carcinoma de Células Escamosas/terapia , Bovinos , Cisplatino/uso terapêutico , Terapia Combinada , Relação Dose-Resposta a Droga , Neoplasias Oculares/terapia , Humanos , Injeções Intralesionais , Linfoma/terapia , Neoplasias Mamárias Experimentais/terapia , Sarcoma de Mastócitos/terapia , Camundongos , Camundongos Endogâmicos DBA , Transplante de Neoplasias , Fatores de Tempo , Células Tumorais Cultivadas , Neoplasias da Bexiga Urinária/terapiaRESUMO
Minimum inhibitory concentrations (MICs) of 30 antimicrobial agents (including the hitherto unreported antimicrobial agents doxycycline, minocycline, vanomycin, 3 quinolones and 3 combinations of antimicrobial agents) for isolates of Salmonella spp. (20), Escherichia coli (17), Klebsiella spp. (8), Proteus spp. (7), Pseudomonas aeruginosa (7), Actinobacillus equuli (5), Rhodococcus equi (4), Streptococcus zooepidemicus (23), Streptococcus equisimilis (6), Streptococcus equi (4), coagulase-positive Staphylococcus spp. (20) and Taylorella equigenitalis (19) were determined using the agar dilution method. All isolates were of equine origin. MICs were compared with recommended MIC breakpoints. The results indicate that, for some of the pathogenic bacteria evaluated, susceptibility testing of isolates from the individual patient is essential to determine an appropriate antimicrobial treatment.
Assuntos
Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Cavalos/microbiologia , Animais , Resistência Microbiana a Medicamentos , Testes de Sensibilidade Microbiana/veterinária , Países Baixos , Staphylococcus/efeitos dos fármacosRESUMO
Equine acute abdominal disease is often associated with shock. Important aspects in the onset of this complication include hypovolaemia, the translocation of endotoxins from the gut and the subsequent activation of the cytokine network. The clinical efficacy of high volume continuous venovenous haemofiltration (HV-CVVH) and the clearance of cytokines were therefore investigated in an equine endotoxaemic model. Ten male Shetland ponies received a slow infusion of LPS (2 microg/kg bwt) under general anaesthesia. The treatment group (n = 5) received HV-CVVH (2 ml/kg bwt/min) using a 75 kD polymethylmethacrylate (PMMA filter). Haemodynamic, blood variable and cytokine (TNF, IL-1 and IL-6) measurements were performed every 30 min for a 6 h period. The ponies showed a typical reaction in mean pulmonary arterial pressure, blood chemical and haematological markers after LPS challenge. No significant differences were found between the treatment group and the control group. Only a slight increase in cardiac index and no marked decrease in mean arterial pressure were seen. A clear cytokine response was found in all ponies, though substantially different in magnitude between individuals. The clearance of cytokines from the blood increased in time, but did not lead to significant decrease in serum levels. In this study, HV-CVVH with a PMMA filter did not prove to have a significant beneficial effect on the course of experimental endotoxaemia in horses. However, in a more severe model, better efficacy might be obtained. Testing additional filters might lead to a more suitable therapy for horses.
Assuntos
Citocinas/sangue , Hemofiltração/veterinária , Doenças dos Cavalos/terapia , Choque Séptico/veterinária , Animais , Modelos Animais de Doenças , Hemodinâmica , Hemofiltração/métodos , Doenças dos Cavalos/sangue , Doenças dos Cavalos/fisiopatologia , Cavalos , Lipopolissacarídeos/toxicidade , Masculino , Choque Séptico/sangue , Choque Séptico/fisiopatologia , Choque Séptico/terapia , Fatores de Tempo , Resultado do TratamentoRESUMO
The plasma penicillin concentrations were determined in 5 horses given an IV injection of sodium penicillin G; plasma penicillin concentrations were also determined in a crossover experiment, where animals were given procaine penicillin G subcutaneously at 1 site and IM at 4 sites. The mean penicillin plasma peak concentration and bioavailability were highest after the drug was injected in the neck and biceps musculature. Injections in the gluteal muscle and in the subcutaneous sites resulted in similar, but lower, more persistent penicillin plasma concentrations and a lower bioavailability than were obtained with injection in the neck and biceps musculature. The pharmacokinetic data obtained after penicillin was administered via the pectoral muscle route exhibited an intermediate position. Therapeutic implications of the routes of administration with respect to hemolytic streptococcal infections are discussed.
Assuntos
Cavalos/metabolismo , Penicilina G Procaína/metabolismo , Penicilina G/metabolismo , Animais , Proteínas Sanguíneas/metabolismo , Nádegas , Injeções Intramusculares , Injeções Intravenosas , Injeções Subcutâneas , Cinética , Pescoço , Músculos Peitorais , Penicilina G Procaína/administração & dosagem , Ligação ProteicaRESUMO
Although the cause of bovine ocular squamous cell carcinoma (BOSCC) is attributed to viruses in addition to cofactors (eg, UV light), to our knowledge, the final causative agent has not been described. Bovine papilloma virus (BPV)-like particles were detected in approximately 33% of various putative precursor lesions of BOSCC. In contrast, it was reported that, using BPV-specific antibodies, it was not possible to detect viral antigens in BOSCC. Fourteen established BOSCC and 9 BOSCC-derived cell lines were examined for BPV DNA. Probes of all 6 known BPV types were used in various hybridization assays. Neither Southern blot analysis, under high and low stringency conditions, nor in situ hybridization resulted in detection of BPV DNA. Papilloma viruses were not observed in electron microscopic studies. Results exclude direct association between BOSCC and BPV types 1 to 6, or as yet unknown closely related BPV types. However, BPV may contribute to induction of precursor lesions or events leading to carcinogenic transformation, without being relevant for maintenance of the tumor.
Assuntos
Papillomavirus Bovino 1/isolamento & purificação , Carcinoma de Células Escamosas/veterinária , Doenças dos Bovinos/microbiologia , DNA Viral/análise , Neoplasias Oculares/veterinária , Animais , Biópsia/veterinária , Southern Blotting , Papillomavirus Bovino 1/genética , Carcinoma de Células Escamosas/microbiologia , Bovinos , Sondas de DNA , Eletroforese em Gel de Ágar , Neoplasias Oculares/microbiologia , Feminino , Hibridização de Ácido Nucleico , Células Tumorais CultivadasRESUMO
In Zimbabwe, ocular squamous cell carcinoma (OSCC) was frequently observed in 5 breeding herds of Simmental cattle, a Bos taurus breed originating from Switzerland. In these herds, initial signs of OSCC were already noticeable in cattle about 3 years old. Gradually, OSCC prevalence increased, and 36 to 53% of cattle over 7 years old had 1 or more tumors. More tumors developed in Simmental cattle with periorbital white skin than in cattle with periorbital pigmented skin. Other breeds of cattle (eg, Friesian) also are partly white-faced and live in Zimbabwe in a comparable environment; yet, OSCC prevalence was lower in those breeds.